Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion type Assertion NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_head.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion description "[We have previously shown that in the human prostate cancer cell line LN-CaP, 1,25-(OH)2D3 mediates an increase in cyclin-dependent kinase inhibitor p27Kip1 levels, inhibition of cyclin-dependent kinase 2 (Cdk2) activity, hypophosphorylation of retinoblastoma protein, and accumulation of cells in G1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion evidence source_evidence_literature NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion SIO_000772 12954644 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion wasDerivedFrom befree-20150227 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion wasGeneratedBy ECO_0000203 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.